ScholarLens Back to search
1984•PubMedRequires access

Effectiveness of psoralens in mycosis fungoides.

Roenigk Hh

Open publisher page 5 citations

Abstract

A 6-year follow-up of 12 patients with mycosis fungoides (MF) treated with psoralen photochemotherapy (PUVA) at the Cleveland Clinic revealed that 7 patients are clear of MF with 4 no longer receiving therapy and 3 on maintenance PUVA. Five patients died within 2 years of onset of therapy. Of 25 others with MF who were treated at Northwestern University, 20 are clear or partially clear after PUVA. Plaque-stage MF responds best to this type of treatment; Sézary syndrome, erythrodermic MF, and tumor-stage MF respond poorly to PUVA.

About this research paper

What this paper is about

A 6-year follow-up of 12 patients with mycosis fungoides (MF) treated with psoralen photochemotherapy (PUVA) at the Cleveland Clinic revealed that 7 patients are clear of MF with 4 no longer receiving therapy and 3 on maintenance PUVA. Five patients died within 2 years of onset of therapy. Of 25 others with MF who were treated at Northwestern University, 20 are clear or partially clear after PUVA. Plaque-stage MF responds best to this type of treatment; Sézary syndrome, erythrodermic MF, and tumor-stage MF respond poorly to PUVA.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A 6-year follow-up of 12 patients with mycosis fungoides (MF) treated with psoralen photochemotherapy (PUVA) at the Cleveland Clinic revealed that 7 patients are clear of MF with 4 no longer receiving therapy and 3 on maintenance PUVA. Five patients died within 2 years of onset of therapy. Of 25 others with MF who were treated at Northwestern University, 20 are clear or partially clear after PUVA. Plaque-stage MF responds best to this type of treatment; Sézary syndrome, erythrodermic MF, and tumor-stage MF respond poorly to PUVA.

Key concepts: Mycosis fungoides, PUVA therapy, Dermatology, Medicine, Psoralen, Stage (stratigraphy), Psoriasis, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effectiveness of psoralens in mycosis fungoides. — Research Paper | ScholarLens